-
公开(公告)号:DE3633496A1
公开(公告)日:1988-04-14
申请号:DE3633496
申请日:1986-10-02
Applicant: HOECHST AG
Inventor: BECKER REINHARD DR , HENNING RAINER DR , RUEGER WOLFGANG DR , TEETZ VOLKER DR , URBACH HANSJOERG DR
IPC: A61K31/40 , A61K31/401 , A61K31/435 , A61K31/44 , A61K38/05 , A61K38/55 , A61K45/06 , A61P3/00 , A61P3/14 , A61P9/12 , A61P43/00 , A61K37/02 , A61K31/47 , A61K31/395 , A61K31/54
Abstract: The combinations are produced as described and used as medicines.
-
公开(公告)号:GR79158B
公开(公告)日:1984-10-02
申请号:GR840173477
申请日:1984-01-10
Applicant: HOECHST AG
Inventor: HENNING RAINER DR , URBACH HANSJORG DR , TEETZ VOLKER DR , BECKER REINHARD DR
IPC: A61K38/00 , A61K38/55 , A61P9/12 , A61P43/00 , C07D209/96 , C07D317/28 , C07D317/30 , C07D317/32 , C07D317/72 , C07K1/02 , C07K1/113 , C07K5/02 , C07K5/06 , C07K5/078 , C07K14/81
Abstract: The invention relates to new spirocyclic aminoacid derivatives of the formula I (I) in which m denotes 1 or 2, n denotes 0 or 1, R denotes hydrogen, alkyl or aralkyl, R1 denotes hydrogen or alkyl which can be optionally substituted by amino, acylamino or benzoylamino, alkenyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, aryl or partially hydrogenated aryl, each of which can be substituted by alkyl, alkoxy or halogen, arylalkyl or aroylalkyl, both of which can be substituted as defined above in the aryl radical, an S- or O- and/or N-heterocyclic radical or a side chain of an alpha -aminoacid, R2 denotes hydrogen, alkyl, alkenyl or aralkyl, Y denotes hydrogen or hydroxyl, Z denotes hydrogen, or Y and Z together denote oxygen and X denotes alkyl, alkenyl, cycloalkyl, aryl, which can be monosubstituted, disubstituted or trisubstituted by alkyl, alkoxy, hydroxyl, halogen, nitro, amino, alkylamino, dialkylamino and/or methylenedioxy, or 3-indolyl, processes for their preparation, agents containing them and their use and new spirocyclic aminoacids as intermediates and a process for their preparation.
-
公开(公告)号:DE3242151A1
公开(公告)日:1984-05-17
申请号:DE3242151
申请日:1982-11-13
Applicant: HOECHST AG
Inventor: URBACH HANSJOERG DR , HENNING RAINER DR , BECKER REINHARD DR
IPC: C07D209/70 , A61K31/40 , A61K31/403 , A61K38/00 , A61K38/55 , A61P9/12 , A61P43/00 , C07D209/58 , C07D221/22 , C07K1/02 , C07K1/113 , C07K5/02 , C07K5/06 , C07K14/81 , C07D403/12
Abstract: The invention relates to new derivatives of tricyclic aminoacids, of the formula I (I) in which n denotes 0 or 1, A denotes -CH=CH- or -CH2-CH2-, R denotes hydrogen, alkyl or aralkyl, R1 denotes hydrogen, or alkyl, which can optionally be substituted by amino, acylamino or benzoylamino, or alkenyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, aryl or partially hydrogenated aryl, each of which can be substituted by alkyl, alkoxy or halogen, or aralkyl or aroylalkyl, both of which can be substituted as defined above, or a monocyclic or bicyclic S-, O- and/or N-heterocyclene radical, or a side chain of a naturally occurring aminoacid, which may be protected, R2 denotes hydrogen, alkyl, alkenyl or aralkyl, Y denotes hydrogen or hydroxyl and Z denotes hydrogen, or Y and Z together denote oxygen, and X denotes alkyl, alkenyl, cycloalkyl, aryl, which can be mono-, di- or tri-substituted by alkyl, alkoxy, hydroxyl, halogen, nitro, amino, alkylamino, dialkylamino and/or methylenedioxy, or 3-indolyl, and physiologically acceptable salts thereof, processes for their preparation, agents containing these compounds and their use, and new bicyclic aminoacids as intermediates and processes for their preparation.
-
公开(公告)号:DE3211676A1
公开(公告)日:1983-10-06
申请号:DE3211676
申请日:1982-03-30
Applicant: HOECHST AG
Inventor: HENNING RAINER DR , URBACH HANSJOERG DR , GEIGER ROLF PROF DR , TEETZ VOLKER DR , BECKER REINHARD DR
IPC: A61K31/40 , A61K31/403 , A61K31/4035 , A61K31/405 , A61K38/00 , A61P9/12 , C07D209/44 , C07D209/52 , C07D217/24 , C07K1/113 , C07K5/02 , C07K5/06 , C07K14/81 , C07D207/34 , C07D401/06 , C07D401/14 , C07D403/06 , C07D403/14 , C07D405/06 , C07D405/14 , C07D217/26 , C07D207/325
Abstract: Compounds of the formula I in which n = 1, 2 or 3, R is hydrogen, unsubstituted or amino-, acylamino- or benzoylamino-substituted alkyl, alkenyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, aryl or partially hydrogenated aryl each of which can be substituted by alkyl, alkoxy or halogen, arylalkyl which as defined above can be substituted in the aryl radical, a mono- or bicyclic heterocyclic radical having up to 10 ring atoms, 1 to 2 ring atoms of which can be sulphur or oxygen atoms and/or 1 to 4 ring atoms of which represent nitrogen atoms or an amino acid side chain, R is hydrogen, alkyl, alkenyl or arylalkyl, Y is hydrogen or hydroxyl, Z is hydrogen or Y and Z together are oxygen and X is alkyl, alkenyl, cycloalkyl, aryl which can be mono-, di- or trisubstituted by alkyl, alkoxy, hydroxyl, halogen, nitro, amino, alkylamino, dialkylamino or methylenedioxy, or indol-3-yl, a process for their preparation, agents containing them, their use as well as intermediates and a process for their preparation.
-
55.
公开(公告)号:CY2191B1
公开(公告)日:2002-11-08
申请号:CY0000027
申请日:2000-06-16
Applicant: HOECHST AG
Inventor: BECKER REINHARD DR , HENNING RAINER DR , TEETZ VOLKER DR , URBACH HANSJOERG DR
IPC: A61K38/55 , A61K31/275 , A61K31/277 , A61K31/40 , A61K31/401 , A61K31/41 , A61K31/425 , A61K31/455 , A61K31/47 , A61K31/55 , A61K45/06 , A61P3/00 , A61P3/14 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00
Abstract: An angiotensin converting enzyme inhibitor (I) can be used in combination with Ca antagonists (III) in the prevention and therapy of proteinuria. Pref. (A) Ramipril and felodipine; (B) Ramipril and 4-(2,3-dichlorophenyl) -2,6-dimethyl-3- (1,2,4-oxadiazol-5-yl) -S-isopropoxy carbonyl-1,4-dihydropyridine (IIb), (c) Trandolapril and felodipine; (D) Trandolapril and (IIb), (E) Trandolapril and Verapamil; (F) Quinapril and felodipine; (G) Quinapril and (IIIb) or the physiologically acceptable salts of these components.
-
公开(公告)号:DK0503162T3
公开(公告)日:1998-12-07
申请号:DK91122406
申请日:1992-01-01
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , ENGLERT HEINRICH DR , KLEEMANN HEINZ-WERNER DR , GERHARDS HERMANN DR , SCHOELKENS BERNWARD PROF DR , BECKER REINHARD DR , LINZ WOLFGANG DR , CAILLE JEAN-CLAUDE , VEVERT JEAN-PAUL
IPC: A61K31/40 , A61K31/415 , A61K31/425 , A61K31/435 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/505 , A61K31/535 , A61K31/54 , A61K31/64 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00 , C07D207/34 , C07D207/36 , C07D233/54 , C07D233/66 , C07D233/68 , C07D233/70 , C07D233/84 , C07D233/90 , C07D249/02 , C07D255/02 , C07D257/02 , C07D257/04 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D453/02 , C07D521/00
Abstract: Azole derivative of the general formula (I) in which A, L, O, R , X, Y, Z and q have the meanings given, a process for their preparation, pharmaceutical preparations and the use of the compounds are described. Azole derivatives of the formula I where the symbols have, for example, the following meanings: R = (C2-C10)-alkyl Z = nitrogen X and Y = independently of one another CR L = -CH2- q = zero or 1 A = biphenyl radical which is substituted, for example, by R R = halogen or hydrogen R = SO2-NH-CO-OR and R = phenyl, are highly active antagonists of angiotensin II receptors.
-
公开(公告)号:ES2079545T3
公开(公告)日:1996-01-16
申请号:ES91119892
申请日:1991-11-21
Applicant: HOECHST AG
Inventor: BECKER REINHARD DR , HENNING RAINER DR , TEETZ VOLKER DR , URBACH HANSJORG DR
IPC: A61K38/55 , A61K31/275 , A61K31/277 , A61K31/40 , A61K31/401 , A61K31/41 , A61K31/425 , A61K31/455 , A61K31/47 , A61K31/55 , A61K45/06 , A61P3/00 , A61P3/14 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00
Abstract: An angiotensin converting enzyme inhibitor (I) can be used in combination with Ca antagonists (III) in the prevention and therapy of proteinuria. Pref. (A) Ramipril and felodipine; (B) Ramipril and 4-(2,3-dichlorophenyl) -2,6-dimethyl-3- (1,2,4-oxadiazol-5-yl) -S-isopropoxy carbonyl-1,4-dihydropyridine (IIb), (c) Trandolapril and felodipine; (D) Trandolapril and (IIb), (E) Trandolapril and Verapamil; (F) Quinapril and felodipine; (G) Quinapril and (IIIb) or the physiologically acceptable salts of these components.
-
公开(公告)号:AT127346T
公开(公告)日:1995-09-15
申请号:AT91119892
申请日:1991-11-21
Applicant: HOECHST AG
Inventor: BECKER REINHARD DR , HENNING RAINER DR , TEETZ VOLKER DR , URBACH HANSJOERG DR
IPC: A61K38/55 , A61K31/275 , A61K31/277 , A61K31/40 , A61K31/401 , A61K31/41 , A61K31/425 , A61K31/455 , A61K31/47 , A61K31/55 , A61K45/06 , A61P3/00 , A61P3/14 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00
Abstract: An angiotensin converting enzyme inhibitor (I) can be used in combination with Ca antagonists (III) in the prevention and therapy of proteinuria. Pref. (A) Ramipril and felodipine; (B) Ramipril and 4-(2,3-dichlorophenyl) -2,6-dimethyl-3- (1,2,4-oxadiazol-5-yl) -S-isopropoxy carbonyl-1,4-dihydropyridine (IIb), (c) Trandolapril and felodipine; (D) Trandolapril and (IIb), (E) Trandolapril and Verapamil; (F) Quinapril and felodipine; (G) Quinapril and (IIIb) or the physiologically acceptable salts of these components.
-
公开(公告)号:ES2061787T3
公开(公告)日:1994-12-16
申请号:ES89109209
申请日:1989-05-23
Applicant: HOECHST AG
Inventor: BECKER REINHARD DR , HENNING RAINER DR , URBACH HANSJORG DR , TEETZ VOLKER DR , ENGLERT HEINRICH CHRISTIAN DR , MANIA DIETER DR
Abstract: The invention relates to combinations of angiotensin converting enzyme inhibitors with potassium channel modulators, process for the preparation thereof and their use as medicines.
-
公开(公告)号:ES2061531T3
公开(公告)日:1994-12-16
申请号:ES88101975
申请日:1988-02-11
Applicant: HOECHST AG
Inventor: URBACH HANSJORG DR , HENNING RAINER DR , SCHOLKENS BERNWARD DR , BECKER REINHARD DR
IPC: C07D223/32 , A61K31/395 , A61K31/445 , A61K31/55 , A61K38/00 , A61P9/00 , A61P9/12 , A61P27/02 , A61P27/06 , A61P43/00 , C07D225/04 , C07D401/12 , C07D403/06 , C07D403/12 , C07D405/12 , C07K5/02 , C07K5/06 , A61K37/02
Abstract: Cyclopenta-azocine and -azepine derivs. of formula (I) and their salts are new. In (I) m = 1 or 2; n = 0-2; R1 and R2 = H; 1-6C alkyl (opt. substd. once by OH, SH, 1-2C alkoxy, 1-2C alkylthio, COOH, 1-2C alkoxycarbonyl, 3-indolyl, imidazolyl, CONH2, amino or guanidino); 2-6C alkenyl; 3-9C cycloalkyl or cycloalkenyl; 3-7C cycloalkyl (1-4C) alkyl; 6-12C aryl (opt. partially hydrogenated) or 6-12C aryl (1-4C) alkyl (opt. OH substd. in aryl); R3 and R4 = H, 1-6C alkyl, 2-6C alkenyl or 6-12C aryl (1-4C) alkyl, opt. substd. in aryl by one MeO or NO2; Y = H or OH; Z = H; or Y and Z are together oxo; X = 1-6C alkyl (opt. substd. by NH2, acylamino, 1-6C alkylamino and/or di(1-4C)alkylamino); 2-6C alkenyl; 5-9C cycloalkyl, 1-R1-piperidin-4-yl, 6-12C aryl (opt. substd. by 1-3 of 1-4C alkyl or alkoxy, OH, halo, NO2, NH2 (itself opt. substd. by 1 or 2 1-4C alkyl) and/or methylenedioxy) or 3-indolyl; any free OH, SH, COOH, amino or guanidino can be protected conventionally.
-
-
-
-
-
-
-
-
-